Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 25 , ISSUE 3 ( March, 2021 ) > List of Articles

EDITORIAL

Melioidosis—Commonly Missed, Yet Not Uncommon and Eminently Treatable

Ram Gopalakrishnan

Keywords : Burkholderia, Carbapenem, Melioidosis

Citation Information : Gopalakrishnan R. Melioidosis—Commonly Missed, Yet Not Uncommon and Eminently Treatable. Indian J Crit Care Med 2021; 25 (3):258-259.

DOI: 10.5005/jp-journals-10071-23749

License: CC BY-NC 4.0

Published Online: 20-03-2021

Copyright Statement:  Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract


PDF Share
  1. Limmathurotsakul D, Golding N, Dance D, Messina JP, Pigott DM, Moyes CL, et al. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat Microbiol 2016;1(1):15008. DOI: 10.1038/nmicrobiol.2015.8.
  2. Arjun R, Ghafur A, Devarajan V, Senthur Nambi P, Ramasubramanian V, Suresh Kumar D, et al. A cluster of cases of melioidosis following floods in Chennai, India. J Contemp Clin Pract 2017;3(2):50–56. DOI: 10.18683/jccp.2017.
  3. Chierakul W, Winothai W, Wattanawaitunechai C, Wuthiekanun V, Rugtaengan T, Rattanalertnavee J. Melioidosis in 6 tsunami survivors in Southern Thailand. Clin Infect Dis 2005;41(7):982–990. DOI: 10.1086/432942.
  4. Solomon CG, LaRocque RC. Climate change—a health emergency. N Engl J Med 2019;380(3):209–211. DOI: 10.1056/NEJMp1817067.
  5. Ganesan V, Murugan M, Sundaramurthy R, Soundaram GVG. Melioidosis in a tertiary care center from South India—a 5-year experience. Indian J Crit Care Med 2021;25(3):327–330.
  6. Gopalakrishnan R, Sureshkumar D, Thirunarayan MA, Ramasubramanian V. Melioidosis: an emerging infection in India. J Assoc Physic India 2013;61(9):24–26.
  7. https://main.icmr.nic.in/sites/default/files/guidelines/Treatment_Guidelines_2019_Final.pdf.
  8. Russo TA, Marr CM. Hypervirulent Klebsiella pneumonia. Clin Microbiol Rev 2019;32(3):e0000119. DOI: 10.1128/CMR.00001-19.
  9. Anunnatsiri S, Chaowagul W, Teparrukkul P, Chetchotisakd P, Tanwisaid K, Khemla S, et al. A comparison between 12 versus 20 weeks of trimethoprim-sulfamethoxazole as oral eradication treatment for melioidosis: an open-label, pragmatic, multicenter, non-inferiority, randomized controlled trial. Clin Infect Dis 2020;ciaa1084. DOI: 10.1093/cid/ciaa1084.
  10. Chetchotisakd P, Chierakul W, Chaowagul W, Anunnatsiri S, Phimda K, Mootsikapun P, et al. Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial. Lancet 2014;383(9919):807–814. ISSN 0140-6736. DOI: 10.1016/S0140-6736(13)61951-0.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.